Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience

INTRODUCTION: Due to the COVID-19 vaccination campaign, national pharmacovigilance (PV) centres had to deal with high volumes of Individual Case Safety Reports (ICSRs) that needed to be processed and assessed in a short time span. This necessitated the development of a dedicated system to enable nea...

Descripción completa

Detalles Bibliográficos
Autores principales: Oosterhuis, Ingrid, Scholl, Joep, van Puijenbroek, Eugène, Kant, Agnes, van Hunsel, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645343/
https://www.ncbi.nlm.nih.gov/pubmed/36350465
http://dx.doi.org/10.1007/s40264-022-01253-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645343/
https://www.ncbi.nlm.nih.gov/pubmed/36350465
http://dx.doi.org/10.1007/s40264-022-01253-5

Ejemplares similares